Authors: Lau, R Wang, F Jeffery, G Marty, V Kuniyoshi, J Bade, E Ryback, ME Weber, J

Citation: R. Lau et al., Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma, J IMMUNOTH, 24(1), 2001, pp. 66-78

Authors: Lee, P Wang, F Kuniyoshi, J Rubio, V Stuges, T Groshen, S Gee, C Lau, R Jeffery, G Margolin, K Marty, V Weber, J

Citation: P. Lee et al., Effects of interleukin-12 on the immune response to a multipeptide vaccinefor resected metastatic melanoma, J CL ONCOL, 19(18), 2001, pp. 3836-3847

Authors: Muderspach, L Wilczynski, S Roman, L Bade, L Felix, J Small, LA Kast, WM Fascio, G Marty, V Weber, J

Citation: L. Muderspach et al., A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive, CLIN CANC R, 6(9), 2000, pp. 3406-3416

Authors: Weber, JS Hua, FL Spears, L Marty, V Kuniyoshi, C Celis, E

Citation: Js. Weber et al., A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma, J IMMUNOTH, 22(5), 1999, pp. 431-440

Authors: Wang, F Bade, E Kuniyoshi, C Spears, L Jeffery, G Marty, V Groshen, S Weber, J

Citation: F. Wang et al., Phase I trial of a MART-I peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma, CLIN CANC R, 5(10), 1999, pp. 2756-2765

Authors: Pullarkat, V Deo, Y Link, J Spears, L Marty, V Curnow, R Groshen, S Gee, C Weber, JS

Citation: V. Pullarkat et al., A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu, CANCER IMMU, 48(1), 1999, pp. 9-21